[1]

GBD 2019 Blindness and Vision Impairment Collaborators (on behald of the Vision Loss Expert Group of the Global Burden of Disease Study). 2021. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet − Global Health 9(2):E144−E160

doi: 10.1016/S2214-109X(20)30489-7
[2]

Virgili G, Curran K, Lucenteforte E, Peto T, Parravano M. 2023. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. The Cochrane Database of Systematic Reviews 2023(6):CD007419

doi: 10.1002/14651858.CD007419.pub7
[3]

Pandit S, Ho AC, Yonekawa Y. 2023. Recent advances in the management of proliferative diabetic retinopathy. Current Opinion in Ophthalmology 34(3):232−36

doi: 10.1097/ICU.0000000000000946
[4]

Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, et al. 2021. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580−91

doi: 10.1016/j.ophtha.2021.04.027
[5]

Sachdeva MM. 2021. Retinal neurodegeneration in diabetes: an emerging concept in diabetic retinopathy. Current Diabetes Reports 21(12):65

doi: 10.1007/s11892-021-01428-x
[6]

Albertos-Arranz H, Martínez-Gil N, Sánchez-Sáez X, Molina-Martín JC, Lax P, et al. 2025. Neuronal degeneration and glial activation in the absence of vascular changes in human retinas of patients with diabetes. Investigative Ophthalmology & Visual Science 66(3):53

doi: 10.1167/iovs.66.3.53
[7]

Sohn EH, van Dijk HW, Jiao C, Kok PHB, Jeong W, et al. 2016. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America 113(19):E2655−E2664

doi: 10.1073/pnas.1522014113
[8]

Silva-Viguera MC, García-Romera MC, Bautista-Llamas MJ. 2023. Contrast sensitivity function under three light conditions in patients with type 1 diabetes mellitus without retinopathy: a cross-sectional, case-control study. Graefe's Archive for Clinical and Experimental Ophthalmology 261(9):2497−505

doi: 10.1007/s00417-023-06057-6
[9]

Koca S, Kılıç D. 2023. Long-term longitudinal retinal changes after conventional and pattern scan laser panretinal photocoagulation in diabetic retinopathy. Photodiagnosis and Photodynamic Therapy 44:103845

doi: 10.1016/j.pdpdt.2023.103845
[10]

Zheng W, Chen S, Ding X, Lai K, Xiao S, et al. 2021. Microinvasive pars plana vitrectomy versus panretinal photocoagulation in the treatment of severe non-proliferative diabetic retinopathy (the VIP study): study protocol for a randomised controlled trial. BMJ Open 11(2):e043371

doi: 10.1136/bmjopen-2020-043371
[11]

Murphy JI, Weaver NE, Hendricks AE. 2022. Accessible analysis of longitudinal data with linear mixed effects models. Disease Models & Mechanisms 15(5):dmm048025

doi: 10.1242/dmm.048025
[12]

Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, et al. 2003. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9):1677−82

doi: 10.1016/S0161-6420(03)00475-5
[13]

Yohannan J, Cheng M, Da J, Chapagain S, Sotimehin A, et al. 2020. Evidence-based criteria for determining peripapillary OCT reliability. Ophthalmology 127(2):167−76

doi: 10.1016/j.ophtha.2019.08.027
[14]

Fang DQ, Yang DW, Mai XT, Cheung CY, Chen HY. 2024. Repeatability, interocular correlation and agreement of optic nerve head vessel density in healthy eyes: a swept-source optical coherence tomographic angiography study. International Journal of Ophthalmology 17(5):896−903

doi: 10.18240/ijo.2024.05.14
[15]

Lai C, Su T, Cao J, Li Q, Du Z, et al. 2024. Retinal neurovascular impairment in full-course diabetic retinopathy: the Guangdong diabetic retinopathy multiple-omics study. Investigative Ophthalmology & Visual Science 65(14):20

doi: 10.1167/iovs.65.14.20
[16]

Zhong X, Li H, Tan S, Yang S, Zhu Z, et al. 2024. Initial retinal nerve fiber layer loss and risk of diabetic retinopathy over a four-year period. Investigative Ophthalmology & Visual Science 65(12):5

doi: 10.1167/iovs.65.12.5
[17]

Early Treatment Diabetic Retinopathy Study Research Group. 1991. Early Photocoagulation for Diabetic Retinopathy. ETDRS Report Number 9. Ophthalmology 98:766−85

doi: 10.1016/S0161-6420(13)38011-7
[18]

Flynn H W, Chew E Y, Simons B D, Barton F B, Remaley N A, et al. 1992. Pars Plana Vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS Report Number 17. Ophthalmology 99(9):1351−57

doi: 10.1016/s0161-6420(92)31779-8
[19]

Šín M, Šínová I, Chrapek O, Prachařová Z, Karhanová M, et al. 2014. The effect of pars plan vitrectomy on oxygen saturation in retinal vessels-a pilot study. Acta Ophthalmologica 92(4):328−331

doi: 10.1111/aos.12238
[20]

Lee SS, Ghosn C, Yu Z, Zacharias LC, Kao H, et al. 2010. Vitreous VEGF clearance is increased after vitrectomy. Investigative Ophthalmology & Visual Science 51(4):2135−38

doi: 10.1167/iovs.09-3582
[21]

Hwang YH, Byun ZY, Hwang DDJ. 2022. Changes in circumpapillary retinal nerve fiber layer thickness after vitrectomy for rhegmatogenous retinal detachment. Scientific Reports 12(1):9630

doi: 10.1038/s41598-022-13070-y
[22]

Lim HB, Lee MW, Kwak BS, Jo YJ, Kim JY. 2018. Longitudinal changes in thicknesses of the macula, ganglion cell-inner plexiform layer, and retinal nerve fiber layer after vitrectomy: a 12-month observational study. Retina 38(1):155−62

doi: 10.1097/IAE.0000000000001509
[23]

Inoue Y, Kadonosono K, Yamakawa T, Uchio E, Watanabe Y, et al. 2009. Surgically-induced inflammation with 20-, 23-, and 25-gauge vitrectomy systems: an experimental study. Retina 29(4):477−80

doi: 10.1097/IAE.0b013e31819a6004
[24]

Sato T, Yamauchi-Mori R, Yamamoto J, Hayashi K. 2022. Longitudinal change in retinal nerve fiber layer thickness and its association with central retinal sensitivity after epiretinal membrane surgery. Asia-Pacific Journal of Ophthalmology 11(3):279−286

doi: 10.1097/APO.0000000000000523
[25]

Lim HB, Shin YI, Lee MW, Park GS, Kim JY. 2019. Longitudinal changes in the peripapillary retinal nerve fiber layer thickness of patients with type 2 diabetes. JAMA Ophthalmology 137(10):1125−32

doi: 10.1001/jamaophthalmol.2019.2537
[26]

Bhaskaran A, Babu M, Sudhakar NA, Kudlu KP, Shashidhara BC. 2023. Study of retinal nerve fiber layer thickness in diabetic patients using optical coherence tomography. Indian Journal of Ophthalmology 71(3):920−26

doi: 10.4103/ijo.IJO_1918_22
[27]

Kwon JW, Oh J. 2022. Aqueous humor analyses in patients with diabetic retinopathy who had undergone panretinal photocoagulation. Journal of Diabetes Research 2022:1897344

doi: 10.1155/2022/1897344
[28]

Lee SB, Kwag JY, Lee HJ, Jo YJ, Kim JY. 2013. The longitudinal changes of retinal nerve fiber layer thickness after panretinal photocoagulation in diabetic retinopathy patients. Retina 33(1):188−93

doi: 10.1097/IAE.0b013e318261a710
[29]

Kim JJ, Im JC, Shin JP, Kim IT, Park DH. 2014. One-year follow-up of macular ganglion cell layer and peripapillary retinal nerve fibre layer thickness changes after panretinal photocoagulation. The British Journal of Ophthalmology 98(2):213−17

doi: 10.1136/bjophthalmol-2013-304349
[30]

Yazdani S, Samadi P, Pakravan M, Esfandiari H, Ghahari E, et al. 2016. Peripapillary RNFL thickness changes after panretinal photocoagulation. Optometry and Vision Science 93(9):1158−62

doi: 10.1097/OPX.0000000000000885
[31]

Jampol LM, Odia I, Glassman AR, Baker CW, Bhorade AM, et al. 2019. Panretinal photocoagulation versus ranibizumab for proliferative diabetic retinopathy: comparison of peripapillary retinal nerve fiber layer thickness in a randomized clinical trial. Retina 39(1):69−78

doi: 10.1097/IAE.0000000000001909
[32]

Bavinger JC, Dunbar GE, Stem MS, Blachley TS, Kwark L, et al. 2016. The effects of diabetic retinopathy and pan-retinal photocoagulation on photoreceptor cell function as assessed by dark adaptometry. Investigative Ophthalmology & Visual Science 57(1):208−17

doi: 10.1167/iovs.15-17281
[33]

Lee HJ, Kang TS, Kwak BS, Jo YJ, Kim JY. 2017. Long-term effect of panretinal photocoagulation on spectral domain optical coherence tomography measurements in diabetic retinopathy. Current Eye Research 42(8):1169−73

doi: 10.1080/02713683.2017.1280510
[34]

Hui Z, Guo X, Bulloch G, Yuan M, Xiong K, et al. 2023. Rates of choroidal loss and ganglion cell-inner plexiform layer thinning in type 2 diabetes mellitus and healthy individuals: a 2-year prospective study. The British Journal of Ophthalmology 108(1):84−90

doi: 10.1136/bjo-2022-321603
[35]

Liang Y, Zhang X, Mei W, Li Y, Du Z, et al. 2024. Predicting vision-threatening diabetic retinopathy in patients with type 2 diabetes mellitus: Systematic review, meta-analysis, and prospective validation study. Journal of Global Health 14:04192

doi: 10.7189/jogh.14.04192